We’ll See You In Court: UK Pharma Challenges Extra NHS Price Hurdle
Executive Summary
The UK's pharmaceutical industry is resorting to the courts to challenge NICE’s new budget impact test, claiming the policies are designed to ration access to new therapies that have already been declared cost-effective.